Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview

TELA Bio

09/08/2025 01:00

TELA Bio Inc TELA.OQ TELA.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 for the period ending June 30 2025

The Malvern Pennsylvania-based  company is expected to report a 28.5% increase in revenue to $20.68 million from $16.09 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for TELA Bio Inc is for a loss of 18 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for TELA Bio Inc is $6.00, about 71.3% above its last closing price of $1.72

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.20
-0.20
-0.25
Missed
-27.8
Dec. 31 2025
-0.24
-0.22
-0.23
Missed
-3.2
Sep. 30 2024
-0.42
-0.40
-0.42
Missed
-3.9‚Äč
Jun. 30 2024
-0.46
-0.47
-0.51
Missed
-8.1
‚Äč‚ÄčMar. 31 2024
-0.51
-0.50
-0.23
Beat
54.1
Dec. 31 2023
-0.42
-0.43
-0.53
Missed
-21.9‚Äč
Sep. 30 2023
-0.49
-0.49
-0.45
Beat
8.5
Jun. 30 2023
-0.53
-0.53
-0.46
Beat
13.7

This summary was machine generated August 9 at 00:00 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)